Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database-Reference-Cited by-同舟云学术

Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database

Published:2017-05-05 Issue:9 Volume:83 Page:2056-2065
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Blin Patrick¹,Dureau-Pournin Caroline¹,Lassalle Régis¹,Jové Jérémy¹,Thomas-Delecourt Florence²,Droz-Perroteau Cécile¹,Danchin Nicolas³,Moore Nicholas¹⁴^ORCID

Affiliation:

1. Bordeaux PharmacoEpi, INSERM CIC1401; Université de Bordeaux; 33076 Bordeaux France

2. AstraZeneca; 92400 Courbevoie France

3. Hôpital Européen Georges Pompidou; 75015 Paris France

4. INSERM U1219; 33076 Bordeaux France

Funder

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13291/fullpdf

Reference34 articles.

1. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;Circulation,2014

2. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction - a hospital registry-primary care linked cohort (MINAP-GPRD);Boggon;Eur Heart J,2011

3. Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US;Stephenson;Curr Med Res Opin,2011

4. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events;Bhatt;N Engl J Med,2006

5. Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial;Berger;Am Heart J,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal antiplatelet therapy for acute coronary syndrome patients with high risk for both ischemia and bleeding;2024-06-12

2. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database;Cardiovascular Diabetology;2024-01-09

3. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database;2023-10-09

4. Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention;BMC Cardiovascular Disorders;2023-03-29

5. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry;American Journal of Cardiovascular Drugs;2022-10-31